26 medicines held by GlaxoSmithKline Biologicals S.A. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) EU/1/09/578/001 |
Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1) | GlaxoSmithKline Biologicals S.A. | — |
| Ambirix suspension for injection in pre-filled syringe Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/005 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus | GlaxoSmithKline Biologicals S.A. | — |
| Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/001 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus | GlaxoSmithKline Biologicals S.A. | — |
| Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/002 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus | GlaxoSmithKline Biologicals S.A. | — |
| Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/003 |
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) | GlaxoSmithKline Biologicals S.A. | — |
| Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/004 |
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) | GlaxoSmithKline Biologicals S.A. | — |
| Cervarix suspension for injection Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed) EU/1/07/419/1-12 |
Hpv 16 l1 protein, Hpv 18 l1 protein | GlaxoSmithKline Biologicals S.A. | — |
| Fendrix suspension for injection EU/1/04/0299/001-003 |
Hepatitis b vaccine | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/001 |
Haemophilus influenzae, Pertussis toxoid, Tetanus toxoid, Polysaccharide-k, Diphtheria toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/002 |
Haemophilus influenzae, Hbs ag, Tetanus toxoid, Pertussis toxoid, Filamentous haemagglutinin | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/003 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/004 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/006 |
Filamentous haemagglutinin, Polysaccharide-k, Diphtheria toxoid, Haemophilus influenzae, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | Marketed |
| Infanrix hexa EU/1/00/152/007 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/008 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/009 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/010 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/011 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/013 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/014 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/015 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/016 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Rotarix oral suspension in pre-filled oral applicator EU/1/05/330/5-11 |
Human rotavirus, live attenuated | GlaxoSmithKline Biologicals S.A. | — |
| Shingrix powder and suspension for suspension for injection. Herpes zoster vaccine (recombinant, adjuvanted). EU/1/18/1272/001-002 |
Recombinant varicella zoster virus surface glycoprotein e | GlaxoSmithKline Biologicals S.A. | — |
| Synflorix suspension for injection in pre-filled syringe EU/1/09/508/001-006 |
Pneumococcal polysaccharide serotype 1, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal polysaccharide serotype 6b, Pneumococcal polysaccharide serotype 7f | GlaxoSmithKline Biologicals S.A. | — |
| Synflorix suspension for injection in vial EU/1/09/508/007-009 |
Pneumococcal polysaccharide serotype 1, Polysaccharide serotype 5, Polysaccharide serotype 6b, Polysaccharide serotype 9v, Polysaccharide serotype 14 | GlaxoSmithKline Biologicals S.A. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.